Advancements in stimulus-responsive gold nanorods for synergistic chemo-photothermal cancer therapy.
Abstract
Cancer is a multifactorial disease characterized by a unique and dynamic tumor microenvironment (TME), along with disrupted tissue architecture and abnormal cellular organization. Conventional anticancer drugs often require high doses for systemic administration, leading to nonspecific tissue distribution and serious side effects. Nanomaterials have significantly impacted cancer treatment by enabling the loading of anticancer drugs into nanocarriers. These nanocarriers can minimize unnecessary systemic toxicity and provide sustained drug release in response to various exogenous (photo/light, temperature) or endogenous (pH, enzymes) stimuli. This approach has led to the development of environment-responsive nanocarriers, designed to ensure targeted delivery of anticancer drugs to specific lesion sites. These nanocarriers enable effective drug release, help overcome the biological barriers that limit conventional treatments, and reduce the required drug dose. Among cancer therapies, conventional chemotherapy (CHT) is a direct treatment method but often causes unintended side effects due to its nonspecific action on both tumor and normal cells. In contrast, patient-friendly photothermal therapy (PTT) offers the potential to treat tumors embedded in vital regions with minimal invasion, though it may not guarantee complete cancer removal. The combination of CHT and PTT, however, presents a promising approach for direct cancer treatment with reduced side effects. In this context, nanostructured materials such as gold nanorods, with optimized size and surface characteristics, play a crucial role in enhancing heating capacity and facilitating active or passive drug delivery to tumor sites. This review summarizes pioneering work on the synergistic combination of chemotherapy and photothermal therapy, with a focus on recent advances in stimulus-responsive nanocarriers for combinational cancer treatment. Additionally, we highlight strategies that enhance gold nanorod-assisted photothermal therapy through its integration with chemotherapeutic agents.